Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

McClatchy Q4 Profit Rises - Quick Facts

RELATED NEWS
Trade MNI now with 

McClatchy Co. (MNI: Quote) reported that its fourth-quarter net income rose to $42.01 million or $0.49 per share, from $14.78 million or $0.17 per share in the same quarter last year.

Adjusted income from continuing operations increased to $43.21 million from $33.48 million in the year ago quarter.

Revenues for the quarter declined to $351.44 million from $369.93 million in the prior year quarter.

Analysts polled by Thomson Reuters expected the company to report earnings of $0.40 per share on revenues of $347.80 million for the quarter. Analysts' estimates typically exclude special items.

Click here to receive FREE breaking news email alerts for McClatchy Co and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
The Swiss economy stalled in the second quarter as the improvement in household spending was insufficient to offset the weakness in exports and investment in construction. Gross domestic product remained flat from the first quarter, when it accelerated to 0.5 percent, the State Secretariat for Economic Affairs said Tuesday. Economists had expected GDP to rise 0.5 percent in the second quarter. Policymakers of Reserve Bank of Australia decided to maintain its record low interest rate once again as they continue to assess that the most prudent course is a period of stability in interest rates. The monetary policy board retained the cash rate at 2.50 percent. The rate has been at the current level since August 2013. A ban on athletes using stamina-boosting gases - xenon and argon - came into effect on Monday. The World Anti-Doping Agency (WADA) said Hypoxia-Inducible Factor (HIF) activators Xenon and Argon have been added to the 2014 List of Prohibited Substances and Methods List following the required three-month notice period and UNESCO's communication to all States Parties. A recommendation to revise the
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.